CYH

Business Context and Reporting Period

Company: Community Health Systems, Inc.
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2008
Overview: The Company is the largest publicly traded operator of hospitals in the U.S. by number of facilities and net operating revenues. The reporting period reflects the integration of the Triad Hospitals, Inc. acquisition (completed July 2007) and the sale of 11 hospitals classified as discontinued operations. As of June 30, 2008, the Company operated 116 general acute care hospitals in continuing operations.

Key Financial Metrics

Note: Debt figures represent total long-term debt ($8,889,915) plus current maturities ($24,279) as of June 30, 2008.

Material Changes vs. Prior Period

• Revenue Growth: Net operating revenues increased 124.6% for the quarter and 130.3% for the six months compared to the prior year. This growth is primarily driven by the inclusion of Triad hospitals and a strong flu season, rather than organic same-store growth (which was 4.9% for the quarter and 5.3% for the six months).
• Profitability: Despite revenue growth, Net Income decreased 10.9% for the quarter and remained flat for the six months. Income from continuing operations declined due to increased operating expenses, depreciation, and significantly higher interest expense.
• Interest Expense: Net interest expense surged to $154.4 million for the quarter (from $29.2 million) and $320.1 million for the six months (from $57.6 million). This increase is attributed to higher average outstanding debt levels following the Triad acquisition and rising interest rates.
• Discontinued Operations: The Company sold 11 hospitals during the period, generating a net gain of $9.6 million on sales for the six months ended June 30, 2008. These results are reported separately from continuing operations.
• Operating Expenses: Operating expenses as a percentage of revenue increased slightly (86.7% vs 85.9% for the quarter), driven by higher supply costs and salaries, partially offset by a decrease in the provision for bad debts.

Guidance, Outlook, and Risks

• Outlook: Management anticipates recognizing all anticipated synergies from the Triad acquisition. The Company does not expect further acquisition activity in 2008 but intends to consider additional acquisitions in 2009. A pending acquisition of a two-hospital system in Spokane, Washington, is expected to close in Q4 2008.
• Capital Resources: The Company maintains a $7.215 billion New Credit Facility. As of June 30, 2008, approximately $1.050 billion was available for borrowing. Management believes internally generated cash flows and available credit are sufficient to fund operations and capital expenditures for the next 12 months.
• Regulatory Risks:
  • Medicaid Reimbursement: The Company was notified of an approximate $8.0 million annual reduction in expected payments from certain Indiana Medicaid programs due to changes in state programs and federal waivers.
  • False Claims Act Investigation: The Department of Justice (DOJ) notified the Company that three New Mexico hospitals may have submitted improper claims for federal funds totaling approximately $27.5 million between 2000 and 2006. The DOJ indicated it would seek treble damages plus penalties if it proceeded to trial. Discussions are ongoing to resolve the matter.
  • Kyphoplasty Investigation: Two hospitals received letters from the U.S. Attorney's Office regarding billing practices for kyphoplasty procedures.
• Debt Covenants: The New Credit Facility and Senior Notes contain restrictive covenants limiting dividends, stock repurchases, and additional indebtedness. The Company is currently in compliance.

Investor Verification Checklist

• Debt Service Coverage: Verify the Company's ability to service its ~$8.9 billion debt load given the significant increase in interest expense and the compression of operating margins.
• Triad Integration: Assess the realization of projected synergies ($42 million realized in Q2 2008) and the completion of the purchase price allocation for Triad, which is expected in Q3 2008.
• Regulatory Exposure: Monitor the resolution of the DOJ False Claims Act investigation regarding New Mexico hospitals and the potential financial impact of the Indiana Medicaid reimbursement reductions.
• Accounts Receivable: Review the allowance for doubtful accounts, which was increased by $70.1 million in late 2007 due to collection deterioration, and monitor days revenue outstanding (54 days as of June 30, 2008).
• Capital Expenditures: Track the $864.2 million estimated cost for six required replacement hospitals, of which $368.5 million has been incurred to date.